WTC
REGN icon

WhitTier Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

WhitTier Trust Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Sell
68
-1
-1% -$681 ﹤0.01% 757
2026
Q1 		$52.6K Buy
69
+16
+30% +$12.2K ﹤0.01% 715
2025
Q4 		$41.2K Sell
53
-28
-35% -$19K ﹤0.01% 746
2025
Q3 		$48.6K Sell
81
-47
-37% -$26.6K ﹤0.01% 701
2025
Q2 		$67.2K Buy
128
+18
+16% +$10K ﹤0.01% 711
2025
Q1 		$69.8K Sell
110
-8
-7% -$5.5K ﹤0.01% 686
2024
Q4 		$84.1K Sell
118
-49
-29% -$41.1K ﹤0.01% 643
2024
Q3 		$176K Sell
167
-2
-1% -$2.23K ﹤0.01% 497
2024
Q2 		$178K Buy
169
+34
+25% +$33K ﹤0.01% 475
2024
Q1 		$130K Sell
135
-30
-18% -$28.5K ﹤0.01% 528
2023
Q4 		$145K Hold
165
– – ﹤0.01% 516
2023
Q3 		$136K Hold
165
– – ﹤0.01% 503
2023
Q2 		$119K Hold
165
– – ﹤0.01% 543
2023
Q1 		$136K Sell
165
-2
-1% -$1.51K 0.01% 507
2022
Q4 		$120K Buy
167
+55
+49% +$40.6K ﹤0.01% 526
2022
Q3 		$77K Buy
112
+57
+104% +$35.9K ﹤0.01% 604
2022
Q2 		$33K Hold
55
– – ﹤0.01% 740
2022
Q1 		$38K Buy
55
+25
+83% +$15.8K ﹤0.01% 721
2021
Q4 		$19K Hold
30
– – ﹤0.01% 819
2021
Q3 		$18K Hold
30
– – ﹤0.01% 855
2021
Q2 		$17K Hold
30
– – ﹤0.01% 814
2021
Q1 		$14K Hold
30
– – ﹤0.01% 820
2020
Q4 		$14K Hold
30
– – ﹤0.01% 798
2020
Q3 		$17K Hold
30
– – ﹤0.01% 757
2020
Q2 		$19K Hold
30
– – ﹤0.01% 725
2020
Q1 		$15K Hold
30
– – ﹤0.01% 738
2019
Q4 		$11K Hold
30
– – ﹤0.01% 829
2019
Q3 		$8K Hold
30
– – ﹤0.01% 854
2019
Q2 		$9K Hold
30
– – ﹤0.01% 842
2019
Q1 		$12K Hold
30
– – ﹤0.01% 805
2018
Q4 		$11K Buy
+30
New +$11K ﹤0.01% 823

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

WhitTier Trust Company's REGN Position: Q2 2026 in Review

WhitTier Trust Company reduced its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q2 2026, selling an estimated $681 and leaving 68 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

WhitTier Trust Company first reported a position in REGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $178K in Q2 2024. 582 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • WhitTier Trust Company held 68 shares of Regeneron Pharmaceuticals worth $46K as of Q2 2026.
  • WhitTier Trust Company sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #757 holding.
  • WhitTier Trust Company first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
  • WhitTier Trust Company's Regeneron Pharmaceuticals position peaked at $178K in Q2 2024.
  • 582 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.